The hepatitis C virus (HCV) infects around 160 million people. Although there are new therapies, HCV infection is one of the most common causes of liver transplantation as these new drugs are very expensive and not used extensively.
Also vaccination against HCV is currently impossible. Scientists at the TWINCORE are now investigating a very close relative of the hepatitis C virus: the "non-primate hepacivirus", (NPHV). This newly discovered viral pathogen infects horses and donkeys and raises questions that will give new insights about the human hepatitis C virus. In a recent study, published in PNAS, the researchers have focused on immune control of NPHV in its natural host, the horse.
One of the biggest problems in developing new approaches against HCV is the extremely narrow host range of the virus: it infects only humans and chimpanzees. Researchers can investigate HCV biology in cell-culture, but this approach cannot mimic the human immune system. Consequently it has been very difficult to develop and investigate vaccination strategies against HCV.
"NPHV is the most similar virus to HCV that we know of." says Dr. Stephanie Pfänder, former scientist at the TWINCORE, now at the Institute for Virology and Immunology (IVI) in Berne. Like HCV, NPHV is also specialized to its host: horses are the natural host of the virus, in addition to donkeys.
And NPHV multiplies mainly within the liver – something also shared between the two viruses. However, unlike humans, horses do not appear to get sick after infection. They show no symptoms, or in a few cases mild symptoms, and usually their immune system has eliminated the virus after a few weeks.
"In our initial studies on NPHV in 2014, we found antibodies against the virus in a high percentage of the studied thoroughbred horses from a renowned breeding program. This means that many of these horses have already been infected with the virus without that the infection being noticed." says Prof. Eike Steinmann, head of the Virus Transmission group at the Institute of Experimental Virology at TWINCORE. Is the "horse-NPHV" pairing perhaps the long-sought after animal model which can help scientists can develop a vaccine against HCV?
To find out, the TWINCORE scientists Eike Steinmann, Stephanie Pfänder and Stephanie Walter, in close cooperation with the horse clinic, the Institute of Pathology and the Institute of Virology of the Foundation of the University of Veterinary Medicine Hannover infected three horses, which had no antibodies against NPHV, under controlled conditions and collected blood for the analysis of immune cells once a week.
"The immune system had eliminated the virus in one case after only one week and in the other two cases after eight weeks," says Stephanie Pfänder. "As we were unable to observe a strong general immune response, we suspect that the defense response of the immune system has mainly occurred in the liver."
With this knowledge the scientists have asked an important: can a first infection with NPHV help to protect against a second infection? "We infected the horses with the same virus strain five months after they had cleared the infections," explains the co-investigator from the Horses Clinics, PD Dr. Jessika Cavalleri. "The horses were protected by their previous infection.
The first infection thus appears to be a ‘vaccination’." And the horses were also immune against another variant of the virus, as further infections could show some months later. However, the genetic range of NPHV is far from the broad diversity of HCV- all known NPH-viruses are quite similar.
"These results could facilitate the development of vaccines for hepatitis C," says Eike Steinmann. "For the first time, we are able to investigate a very similar virus to the HC virus in its natural host - which is still able to ward off the virus."
Pfaender S, Walter S, Grabski E, Todt D, Bruening J, Romero-Brey I, Gather T, Brown RJP, Hahn K, Puff C, Pfankuche VM, Hansmann F, Postel A, Becher P, Thiel V, Kalinke U, Wagner B, Bartenschlager R, Baumgärtner W, Feige K, Pietschmann T, Cavalleri JM, Steinmann E (2017). Immune protection against re-infection with non-primate hepacivirus. PNAS published ahead of print March 8, 2017, doi:10.1073/pnas.1619380114
Dr. Jo Schilling | idw - Informationsdienst Wissenschaft
Barium ruthenate: A high-yield, easy-to-handle perovskite catalyst for the oxidation of sulfides
16.07.2018 | Tokyo Institute of Technology
The secret sulfate code that lets the bad Tau in
16.07.2018 | American Society for Biochemistry and Molecular Biology
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.
Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
16.07.2018 | Physics and Astronomy
16.07.2018 | Life Sciences
16.07.2018 | Earth Sciences